Waycross Partners, LLC Edwards Lifesciences Corp Transaction History

Waycross Partners, LLC

$723 Million
Q3 2024

A detailed history of Waycross Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Waycross Partners, LLC holds 187,562 shares of EW stock, worth $14.2 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

187,562

Previous 166,766 12.47%

Holding current value

$14.2 Million

Previous $15.4 Million 19.65%

% of portfolio

1.71%

Previous 2.36%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$59.7 - $93.78 $1.24 Million - $1.95 Million	20,796 Added 12.47%	187,562 $12.4 Million
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $2.72 Million - $3.05 Million	32,296 Added 24.02%	166,766 $15.4 Million
Q1 2024 May 02, 2024	BUY	$72.54 - $95.56 $808,748 - $1.07 Million	11,149 Added 9.04%	134,470 $12.8 Million
Q4 2023 Feb 05, 2024	SELL	$61.71 - $77.76 $459,554 - $579,078	-7,447 Reduced 5.69%	123,321 $9.4 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $473,390 - $638,065	6,833 Added 5.51%	130,768 $9.06 Million
Q2 2023 Jul 26, 2023	BUY	$81.41 - $94.33 $2.21 Million - $2.56 Million	27,144 Added 28.04%	123,935 $11.7 Million
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $1.27 Million - $1.44 Million	17,035 Added 21.36%	96,791 $8.01 Million
Q4 2022 Feb 06, 2023	BUY	$68.3 - $87.44 $5.45 Million - $6.97 Million	79,756 New	79,756 $5.95 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $3.64 Million - $4.34 Million	-35,366 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$83.84 - $104.76 $1.47 Million - $1.83 Million	17,513 Added 98.1%	35,366 $3.66 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $1.62 Million - $2.02 Million	-19,298 Reduced 51.94%	17,853 $285 Million
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $287,890 - $331,761	-3,659 Reduced 8.97%	37,151 $3.11 Million
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $2.93 Million - $3.72 Million	40,810 New	40,810 $3.72 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.

Account

Waycross Partners, LLC Edwards Lifesciences Corp Transaction History